Cite

HARVARD Citation

    Jänne, P. et al. (n.d.). KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Advanced/ Metastatic Non–Small-Cell Lung Cancer (NSCLC) Harboring KRAS G12C Mutation. European journal of cancer. pp. S1-S2. [Online]. 
  
Back to record